Survivorship In Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, And Functional Status Among Long-term Ipilimumab Survivors At A Single Referral Center
Douglas B. Johnson, Debra L. Friedman, Elizabeth Berry, Ilka Decker, Fei Ye, Shilin Zhao, Alicia K. Morgans, Igor Puzanov, Jeffrey A. Sosman, Christine M. Lovly
Twitter
Facebook
LinkedIn
Email